Results 201 to 210 of about 114,789,047 (289)

Efficacy and Safety of Sodium Hyaluronate Injection for Moderate‐To‐Severe Neck Wrinkles: A Multicenter, Single‐Blind, Randomized, Parallel‐Controlled Trial

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Hyaluronic acid (HA) occupies the micro‐environment of the dermal matrix, filling depressions and imparting a smooth appearance to the skin. HA fillers are widely used for wrinkle correction. Still, the efficacy and safety of ANN0032, a new HA‐based injection, have not yet been assessed in clinical trials for moderate to severe neck
Ji‐Na Zheng, Jianming Yang, Kai Yang, Zhiyu Liu, Qian Yu, Xiaoke Liu, Xiuli Li, Shuqin Zhang, Man Hu, Hongyue Diao, Julien Cle'ment, Shiliang Wang, Yuxin Hou, Hengtao Li, Yuna Luo, Kun Chen, Jiajia Liu, Yougai Huang, Weiwei Li, Yan Liu, Yuling Shi, Jun Gu, Yu Gong   +22 more
wiley   +1 more source

Add-on benefits of botulinum toxin type A in combination or sequential therapies for scar management: a systematic review and meta-analysis. [PDF]

Front Pain Res (Lausanne)
Ma Y, Qu W.
europepmc   +1 more source

Botulinum Toxin Type A in Spasticity and Cervical Dystonia: Practical Clinical Recommendations from a Mexican Multidisciplinary Panel of Specialist Injectors. [PDF]

Toxins (Basel)
Hernández Franco J, Santamaría Molina SJ, Zorrilla Sánchez JJ, Carranza Del Río J, Villavicencio IS, Hernández SD, Duvignau Dondé E, González Usigli HA, González López YS, Leal Ortega R, Flores Salinas AA, Alonso LAM, Hernández JFJG, Fernández Bravo M, Vázquez PIA.   +14 more
europepmc   +1 more source

Trends and off-label use of botulinum toxin type A in Chinese neurological practice from 2016 to 2023: a real-world study. [PDF]

Front Pharmacol
Guo S, Jiang H, Huo J, Zhao Z, Li C.
europepmc   +1 more source

Beyond Volumization: Repositioning Hyaluronic Acid Fillers as Anatomy‐Guided Structural Support Tools in the Era of Biostimulators

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Hyaluronic acid (HA) fillers remain widely used in facial rejuvenation, yet concern about overfilled syndrome and unnatural volumization has shifted attention toward biostimulators. These concerns may reflect a mismatch between volumetric treatment logic and structural problems of facial aging. Objective To propose an anatomy‐guided
Tara Margarella, Seung Jun Shin
wiley   +1 more source

Botulinum toxin type E alleviates trigeminal neuropathic pain via modulation of the HIF-1α-NLRP3 pathway. [PDF]

Front Toxicol
Son J, Kim Y, Ju J, Kim J, Nam J, Cha Y, Ahn D.   +6 more
europepmc   +1 more source

Prolonging the Efficacy of Botulinum Toxin A Using a Novel Toxin Mimetic Complex and Peptide Formulation

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Botulinum toxin type A (BTX‐A) is the cornerstone for treating dynamic wrinkles; however, it requires reinjection every 3–4 months. Adjunctive topical creams that mimic the effect of BTX‐A and enhance its action may prolong treatment intervals.
Riad Kassem, Tomer Mimouni, Lee Magal, Ziad Khamaysi, Avner Shemer   +4 more
wiley   +1 more source

Preoperative Botulinum Toxin Type A Use in Giant Inguinal Hernia Repair: A Scoping Review. [PDF]

Med Sci (Basel)
Fernicola A, Ricciardelli L, Cece A, Porcaro F, Parmeggiani D, Santangelo M, Quarto G.   +6 more
europepmc   +1 more source

Topical Epidermal Growth Factor in Acne Vulgaris and Acne‐Related Sequelae: Mechanistic Rationale, Clinical Evidence, and Formulation Challenges

Journal of Cosmetic Dermatology, Volume 25, Issue 9, September 2026.
ABSTRACT Background Acne vulgaris (AV) is a common chronic inflammatory skin disorder, particularly among adolescents and young adults, and its management remains limited by variable treatment response, poor adherence, and treatment‐related adverse effects.
Nasim Gholizadeh, Ghasem Rahmatpour Rokni, Maryam Sahafi, Omid Mohaghegh, Ardalan Etemadzadeh, Reyhaneh Pasandipour, Hamed Fakhrabadi, Ghazal Zoghi   +7 more
wiley   +1 more source

The Use of Botulinum Toxin Type A in Esophageal Atresia Management: a Randomized, Controlled, Investigator-blinded Feasibility and Exploratory Trial in Piglets. [PDF]

Sci Rep
Svensson E, Zvara P, Hagander L, Rasmussen L, Qvist N, Möller S, Schrøder HD, Hejbøl EK, Abdelkhalek AS, Bjørn N, Peterson SÁ, Larsen KC, Omling E, Salö M, Muensterer OJ, Ellebaek MB.   +15 more
europepmc   +1 more source